Clinical Evaluation of Cinepazide (Brendil) in the Treatment of Vertigo

Abstract

Cinepazide (Brendil) was administrated to 30 patients with vertigo and evaluated its effectiveness. The results were as follows.(1) Subjective symptoms were improved in 90% of Ménière's disease, 66.7% of paroxysmal positional vertigo and 70% of other vertigenous diseases.(2) Rotatory vertigo was improved in 78.2%, swaying dizziness in 46.6%, equilibrium disturbance in 75%. Furthermore, nausea was reduced in 80%, heavy-head and headache in 92.9% and stiff shoulders in 95.7%.(3) Although many patients had no objective findings, the findings which was noted were reduced in 61.5%. In all cases, there were no side effects of this drug. These results suggest that Brendil is useful in the treatment of the patients of vertigo.